ArticleNeurology and therapy2024

Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.

Wenyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.